Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Neuroblastoma-targeted nanoparticles entrapping siRNA specifically knockdown ALK.

Neuroblastoma-targeted nanoparticles entrapping siRNA specifically knockdown ALK. Mol Ther. 2011 Jun; 19(6):1131-40.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.